Boston Scientific stent litigation
This article was originally published in The Gray Sheet
Executive Summary
Delaware jury finds Nir stent - developed by Medinol and acquired by Boston Scientific - infringing one of Johnson & Johnson's Palmaz patent claims in March 24 retrial case. Monetary damages will be determined at a yet-to-be-scheduled hearing. The ruling will not affect Boston Scientific's future sales because the firm no longer markets stents on the Nir platform (1"The Gray Sheet" Dec. 8, 2003, p. 23)...